Cas:124521-15-9 N-pentyl-N-(pyridin-3-ylmethyl)nitrous amide manufacturer & supplier

We serve Chemical Name:N-pentyl-N-(pyridin-3-ylmethyl)nitrous amide CAS:124521-15-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

N-pentyl-N-(pyridin-3-ylmethyl)nitrous amide

Chemical Name:N-pentyl-N-(pyridin-3-ylmethyl)nitrous amide
CAS.NO:124521-15-9
Synonyms:N’-Nitrosopentyl-(3-picolyl)amine;N-Nitroso-N-pentyl-3-pyridinemethanamine,NNPA
Molecular Formula:C11H17N3O
Molecular Weight:207.27200
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:45.56000
Exact Mass:207.13700
LogP:2.75520

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like N’-Nitrosopentyl-(3-picolyl)amine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,N-Nitroso-N-pentyl-3-pyridinemethanamine,NNPA physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,N-Nitroso-N-pentyl-3-pyridinemethanamine,NNPA Use and application,N’-Nitrosopentyl-(3-picolyl)amine technical grade,usp/ep/jp grade.


Related News: China has granted conditional approval to its first self-developed treatment for Alzheimer��s disease, a move that may point to revived opportunities in a therapeutic area where drugmakers have burned billions of dollars without yielding a validated new drug. N-pentyl-N-(pyridin-3-ylmethyl)nitrous amide manufacturer Subsequently, the company launched the drug under the brand names ‘Remo’ and ‘Remozen’. N-pentyl-N-(pyridin-3-ylmethyl)nitrous amide supplier API and raw material are often confused due to the similar usage of the two terms. N-pentyl-N-(pyridin-3-ylmethyl)nitrous amide vendor China has granted conditional approval to its first self-developed treatment for Alzheimer��s disease, a move that may point to revived opportunities in a therapeutic area where drugmakers have burned billions of dollars without yielding a validated new drug. N-pentyl-N-(pyridin-3-ylmethyl)nitrous amide factory Subsequently, the company launched the drug under the brand names ‘Remo’ and ‘Remozen’.